CLINICAL_TRIALS
trial_result
· 2022-04-08
Clinical Trial Update: Baricitinib in Relapsing Giant Cell Arteritis [Phase 2]
Summary
Phase 2 trial update for baricitinib in relapsing giant cell arteritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Matthew J Koster | Conditions: Arteritis, Giant Cell | Phase 2 | Status: COMPLETED | Results posted: 2022-04-08